Alice Bjerregaard

Alice Bjerregaard is an experienced professional in drug safety and pharmacovigilance, with a decade of expertise in the pharmaceutical industry. As the Director and Head of Safety Surveillance at ALK, they manage a team of specialists responsible for global safety surveillance tasks. Prior to this role, Alice held various positions at Novo Nordisk, advancing from Safety Surveillance Advisor to Senior Safety Surveillance Adviser, where they oversaw clinical development and pharmacovigilance activities. Alice's educational background includes a PhD in Cancer from the University of Copenhagen and a Diploma in Pharmacovigilance.